TP53 and glioma: Hence, our findings will further gain knowledge on how to improve the efficacy of Ph-PDT on gliomas by inhibiting the expression of ALKBH2. Further research is required to elucidate the function of TP53 and other regulators in controlling ALKBH2 expression after Ph-PDT.